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Objective 
We investigated the relationship between paravertebral muscle cross-sectional area (PVM 
CSA) at the third vertebra (C3) level using CT neck images, and its relationship with 
complications after total laryngectomy. 
Design 
Retrospective analysis of 60 advanced laryngeal cancer patients who underwent total 
laryngectomy was performed. The cross-sectinal areas of paravertebral neck muscles using 
neck computerized tomography (CT) at C3 level images obtained preoperatively were 
analysed.  
Results 
A significant difference in PVM CSA between complication and no complication groups 
[F(1,53=4.319, p=0.043] was identified by ANCOVA. There were no significant differences in 
between-subject effects: T-stage [F=1.652, p=0.204], BMI [F=0.889, p=0.35], Albumin 
[F0.359, p=0.552], Age [F=1.623 p=0.208], Smoking [F 4.319, p=0.41]. 
Conclusion 
PVM CSA measured at C3 level on pretreatment CT may help identify patients at higher risk 
of postoperative wound complications after total laryngectomy and who may particularly 
benefit from pre-operative optimization of nutritional status.  
Keywords: Total laryngectomy, lean muscle mass, sarcopenia, pharyngocutaneous fistula, 
cross-sectional area 
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Neck muscle mass index as a predictor of post laryngectomy wound complications 
Introduction 
Patients with laryngeal cancer experience loss of major weight and skeletal muscle mass (SMM), 
prior to and during therapy, which is associated with poor functional and survival outcomes.1 30–
60% of head and neck cancer patients have malnutrition, related to the tumour and treatment.2 
These patients have a high incidence of complications after major head and neck surgery that can 
delay the start of adjuvant therapy and add to the cost of health care.3 Pharyngocuteous fistule (PCF) 
and hematomas are the most common complications following total laryngectomy (TL).4,5 The PCF 
incidence varies from 2.6% to 65.5%.6 Factors associated with PCF formation include low body mass 
index (BMI), poor nutritional status as well as pre-operative radiotherapy and chemotherapy, male 
gender, increased age, tobacco and alcohol history, tumour site, size and stage, intra-operative flap 
reconstructions, tracheoesophageal puncture and pre-operative tracheostomy.7-10  
In head and neck cancer, indicators of nutritional status including serum protein concentrations and 
serum albumin, when low, are associated adverse outcomes.1,11 Due to their variability these 
faĐtoƌs iŶdiǀidually aƌe uŶaďle to deteĐt a patieŶt͛s ŶutƌitioŶal status.ϭϮ As suĐh, theƌe is a ŵoǀe 
away from these biomarkers and a focus towards patient energy intake, anthropometric 
measurements (BMI, body composition, weight) and functional measures.13,14 
The loss of skeletal muscle mass (SMM) leads to objective weakness, is associated with functional 
impairment and disability15, a longer hospital stay16, higher economic burden, higher risk of 
nosocomial infections17, and decreased survival in both nonmalignant15,18 and malignant 
conditions19-21 and predicts chemotherapy toxicity22 and may be valuable in assessing patients 
prior to surgery. Although patients who lost more than 10% of their ideal body weight are at 
increased risk of postoperative complications23, weight loss alone poorly predicts outcome in head 
and neck cancer (HNC) patients when compared with depleted SMM.24  Low SMM is an independent 
predictive factor for chemotherapy toxicity in patients with advanced HNC treated with primary 
chemoradiotherapy. 25 Grossberg et al24 found that BMI and SMM depletion were powerful 
prognostic indicators of mortality. Nevertheless, BMI alone is not a reliable indicator of SMM.26  
Sarcopenia was initially defined as muscle mass two standard deviations below that of a healthy 
adults27, there is now no clear definition of sarcopenia or one cut-off value for SMM that is valid for 
all oncological patients.28  
The use of functional imaging techniques such as dual-energy X-ray absorption (DEXA) and magnetic 
resonance imaging (MRI), has improved the measurement of SMM. Studies using CT/MR imaging of 
the psoas muscle crosssectional area (CSA) at the level of the third lumbar (L3) vertebra28,29 have 
been used to estimate overall SMM. Assessing paravertebral muscle cross-sectional area (PVM CSA) 
on CT-scan at the third cervical (C3) vertebra appears to be a good alternative to abdominal CT-scans, 
based on the strong correlation between skeletal muscle cross sectional area at C3 and L3 
vertebrae.30 The C3 level is preferred as it captures only the neck muscles. Higher cervical images 
include the tongue muscles while lower levels capture the trapezius muscle. The C3 level includes the 
following muscles, longus capitis, longus colli muscles located anterior to vertebrae and spinalis 
cervicis, semispinalis cervicis, semispinalis capitis, splenius capitis, and levator scapulae muscles. 
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There is currently little literature on the effect of sarcopenia on laryngeal cancer outcomes and no 
practical diagnostic tools for detecting sarcopenia. As laryngeal cancer staging includes cross 
sectional imaging of the neck as routine and a skeletal muscle mass estimate using C3 level CT-scans 
is practical and can be used to reliably to estimate SMM, this may be a cost effective and widely 
available tool to preoperatively assess patients prone to postoperative complications among HNC 
patients. Abdominal CT scans that include the third lumber vertebra (L3) and DEXA-scans are not 
routinely performed in HNC patients. 
As sarcopenia and low SMM are associated with increased postoperative wound complications in 
patients with HNC31, we investigated the relationship between PVM CSA at C3 using CT neck images, 
and complications in advanced laryngeal cancer patients. 
 Methods 
A single-center-retrospective analysis of 77 laryngeal cancer patients who underwent total 
laryngectomy between January 1, 2010, to January 31, 2017 was performed. Data was collected from 
January 1, 2010, to March 31, 2017. Patients with wide tumor resections including skin, extended 
pharyngeal resection requiring flap reconstruction (n=3) and patients with positive surgical margins 
(n = 7) were excluded as these are risk factors for PCF32, 33, patients with missing pre-operative CT 
images (n=7) were excluded. Patients who had head and neck CT scans with a maximum interval of 
two months (n=2) prior to total laryngectomy surgery were included (n = 60). All patients were 
discussed at a multidisciplinary tumor board. Total laryngectomy was preferred in cases where lung 
capacity was insufficient for partial surgery (FEV1 < 60%), > 1 cm subglottic tumor extension, 
interaritenoid and postcricoid involvement, extralaryngeal extension, and vocal cord fixation due to 
cricoarytenoid joint invasion. The laryngectomies were performed with an open technique and 
simultaneous selective neck dissection (levels II-IV +/- IV); prophylactic (n=21) or therapeutic (n=39). 
Informed consent was obtained from 52 patients, 5 patients died and no contact information was 
available for 3. The institutional ethics committee approved the study.  
Patient demographics  
Data including age, hospital stay time, BMI, smoking status, preoperative albumin levels, and co-
existing morbidity (Charlson Comorbidity Index (CCI) scores34 were collected, as well as stage and 
prior treatment history including chemotherapy and radiation. The need of a pedicled or free flap for 
reconstruction was also included. Disease was staged per the American Joint Committee on Cancer 
using the TNM system.35 Advanced-stage laryngeal squamous cell carcinoma (LSCC) was defined as 
T3–T4 and any TN+, M+. Surgery-related wound complications (including infection, 
pharyngocutaneous fistula, dehiscence, hematoma, and seroma) defined as occurring within 30 
postoperative days were recorded. 
Cross-sectional measurement of skeletal muscle index at C3 
By calculating the cross-sectional area (CSA) of neck muscles using staging CT images obtained 
preoperatively and using the method devised by Swartz et al30 we estimated SMM. Swartz et al. 
recently presented a method to estimate skeletal muscle mass in routinely performed head and neck 
CT-scans; CSA at C3 strongly correlated with L3 muscle CSA. The middle of the C3 vertebrae was 
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chosen as the reference point on sagittal reformatted image and CSA measurement undertaken on 
the axial image at this level.  
“keletal ŵusĐle ǁas ƋuaŶtified ďy the use of staŶdaƌd HouŶsfield uŶit ;HUͿ thƌesholds ;−Ϯϵ to ϭϱϬͿϯϲ 
Separately, the cross-sectional area of pixels that had a radiodensity between _29 and +150 HU was 
retƌieǀed ;fuƌtheƌ ƌefeƌƌed to as ͚͚HU ŵusĐle aƌea͟Ϳ. LoŶgus Đapitis, loŶgus Đolli ŵusĐles, spiŶalis 
cervicis, semispinalis cervicis, semispinalis capitis, splenius capitis, and levator scapulae muscles were 
evaluated. The muscles were outlined using an image-processing system (PACS, Infinit Healthcare, 
South Korea, Guro-gu) by a single head and neck radiologist. The cross-sectional areas within the 
limits of the drawn boundaries was calculated using Xelis 3D software (V1.0.6.1, Infinit Healthcare, 
South Korea, Guro-gu ) were measured (Figure 2). The sum of the cross-sectional areas (mm2) of all 
muscles was calculated for each patient; the total area was then normalised for patient height (Cross 
Sectional Area (CSA) mm2/m2) to give a C3 skeletal muscle index.37 
 
Exclusion of sternocleidomastoid muscles 
Swartz et al. presented two methods to estimate skeletal muscle mass in routinely performed head 
and neck CT-scans. They assessed the correlation between CSA at L3 and PVM only and between L3 
and the PVM and only a single SCM muscle. Swartz et al found significant correlation between the 
sum of the PVM and SCM muscles and L3 (r = 0.785, p < 0.001) and the PVM muscles only and L3 (r = 
Ϭ.ϳϳϴ, p < Ϭ.ϬϬϭͿ. Hoǁeǀeƌ as the foƌŵeƌ ǁas ͞the stƌoŶgeƌ ĐoƌƌelatioŶ͟ they oŶly performed further 
analysis on the sum of the PVM and SCM muscles.  
 
This approach had several limitations that they alluded to in their section sub-titled ͚CliŶiĐally ŵissiŶg 
data͛. IŶ theiƌ study C“A assessŵeŶt of oŶe oƌ ďoth “CM ŵusĐles ǁas iŵpaiƌed ďy lymph node 
metastases in 8 SCMs in 6 patients (7.6% of all HNC patient SCMs, 11.5% of all HNC patients, 17.6% of 
patients with neck metastases). 
 
As such we agreed with Scwartz et al that CSA L3 correlated with CSA PVM alone, but disagreed with 
them that the PVM and SCM method of measuring neck CSA was best for further analysis. Stronger 
correlation is not reason enough to ignore the fact that in a significant proportion of patients data is 
not available, as the SCM muscles is invaded by lymph node metastases (Figure 1).   
 
To minimise measurement inconsistency for our study we elected to use Schwartz et als first method 
that excluded the SCM muscles from the CSA calculations. Our study included 12 patients with N2c 
(bilateral) nodal involvement.  
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Statistical analysis 
A one-way analysis of covariance (ANCOVA) was performed using SPSS statistical package for Mac 
version 23 (SPSS Inc., Chicago, Illinois) to investigate if there was a difference in LMM in complication 
and no complication groups. Statistical significance was defined as p < 0.05. Covariates included were 
BMI, albumin, age, T-stage (categorized as 2, 3 or 4) and smoking status. Complication or no 
complication groups were defined as the independent variable. This allowed the creation of 95% 
confidence intervals (CI) for the LMM dependent variable. 
Results 
Patient demographics 
Table 1 summarizes the clinical characteristics of 60 patients; all were men with a mean (SD) age of 
59.4 (8.4) years.  Hypoalbuminemia was identified preoperatively in 25 (41.6 %) patients. Among 
these study patients, 46 (76.6%) had locally advanced disease (T3–4), 14 (23.4 %) had T2 disease. 
Twenty one (35%) patients had N0 neck; 17 (28%), 5 (8%), 3 (13%), 12 (20%) and 2 (3%) patients had 
N1, N2a, N2b, N2c and N3 nodal involvement, respectively. None of the patients had detected 
distant metastasis. Nine patients (15%) had a history of prior chemo/RT.   
Wound Complications  
Wound complications occurred in 22 patients out of 60 (37%). One patient developed chyle leak, 1 
had seroma, PCF, wound dehiscence and hematoma together, 1 had hematoma and seroma 
together, 8 had PCF, 3 had seroma, and 7 experienced dehiscence of their neck incision in the 
absence of a recognized salivary fistula (Table 2). PCFs occurred in 10 patients (16%); six (60%) were 
managed conservatively and four required surgical closure with pectoralis major flap. Regarding 
wound dehiscence (n=8), spontaneous closure with local wound care was noted in 6 (75%) patients 
whereas a surgical closure was necessary in two.  
Cross-sectional skeletal muscle index and postoperative complications  
Of the 60 patients 38 22 were categorized in the complications group and 22 38 in the no 
complications group. ANCOVA identified a significant difference in PVM CSA between complication 
and no complication groups [F (1,53=4.319, p=0.043] (Table 3). There were no significant differences 
in between-subject effects: T-stage [F=1.652, p=0.204], BMI [F=0.889, p=0.35], Albumin [F0.359, 
p=0.552], Age [F=1.623 p=0.208], Smoking [F 4.319, p=0.41]. Estimated marginal means accounting 
for covariates are shown in figure 3. Covariates in the model are evaluated at the following values: T 
stage = 3.0167, BMI = 23.5787, Albumin = 3.6492, Age = 59.3667, smoking = .50 
Postoperative complications related to other variables 
The focus of this study was the relationship between SMM, estimated by PVM CSA, and post 
operative complications. The relationship between postoperative complications and variables BMI 
and T-stage are widely known and we did not concentrate on within this study. However we analysed 
the data using t-tests looking for differences between the complication and non-complication within 
this study. Only BMI showed a significant difference between groups as an independent variable. This 
difference between groups is corrected for in the ANCOVA and not explored further. 
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Discussion 
Postoperative wound complications account for most complications after major head and neck 
surgery.38 Adequate nutritional status is necessary to support wound healing and surgical 
recovery.39 
Our study shows that lean muscle mass estimated by PVM CSA at C3 may be a potentially useful 
predictor of post-operative wound complications in in laryngeal cancer patients.  We found that PVM 
CSA level below 815 mm2/m2 is a potential prognostic indicator of postoperative wound 
complication independent of other factors, such as BMI, hypoalbunemia, smoking history, and 
previous chemo/radiotherapy.  
Grossberg24 et al reported that patients with HNSCC and low SMM at presentation or after 
treatment exhibit decreased overall and cancer-specific survival. Weight loss itself poorly predicts 
outcome in HNC patients when compared with depleted SMM. Therefore, weight loss alone cannot 
be used reliably to stratify by risk patients with larynx cancer undergoing laryngectomy.  In our study, 
we also did not find a statistically significant difference between the complication and no 
complication groups using PVM CSA with regards to T-or N-stages, or low preoperative albumin. 
Radiologically assessed muscle mass has been suggested as a surrogate marker of functional 
status pƌeǀıously.ϯϳ,ϰϬ Puďlished studies use Đƌiteƌia that aƌe study speĐifiĐ, ǁith soŵe studies usiŶg 
imaging modalities such as CT or DEXA scans and others basing their criteria on muscle strength due 
to the cost effectiveness of the measurements.26-29,37 In the present study, Image analysis was 
performed as described in a previous report.16 For the purpose of comparing to literature values, 
measurements for skeletal muscle measured by CT were Ŷoƌŵalized to eaĐh patieŶt͛s height.ϰϭ 
Limitations of our study include, retrospective data collection, lack of female patients and sample 
size. Another limitation in our study in a few (n=2) patients, the interval between CT and 
laryngectomy was up to two months, and arguably there may have been significant weight loss in 
that time.   The number of independent variables included in the ANCOVA was limited by the sample 
size, and the number of wound complications and PCF. This may explain why we did not have a 
significant difference between complications and disease stage. A larger and more homogeneous 
patient cohort is warranted.  
This study, to our knowledge, is the first to investigate the role of PVM CSA measured at the C3 
vertebrate level and postoperative wound complication rate among larynx cancer patients. The lower 
boundary of the 95% CI no complication rate is 815 mm2/m2 and the upper boundary of the 95% for 
the complication group is 850 mm2/m2. We propose that a neck muscle index below 815 mm2/m2 is 
considered as a risk factor for postoperative wound complications in head and neck patients that can 
be used as additional factor for stratifying low muscle mass and subsequent postoperative 
complication risk. We suggest this figure to research colleagues in head and neck surgery for future 
validation studies.  
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Conclusion 
Paravertebral muscle cross-sectional area (PVM CSA) at the third vertebra (C3) level may 
help predict patients at high risk of postoperative wound complications before total 
laryngectomy and who would particularly benefit from pre-operative optimization of 
nutritional status. The incorporation of CT-assessed muscle mass into routine pre-surgical 
assessment may aid nutritional status assesment. 
 
Abbreviations: LMM: Lean muscle mass, SMM: Skeletal muscle mass, PCF: 
Pharyngocutaneous fistule, TL: Total laryngectomy, SCM: Sternocleidomastoid muscle, BMI: 
body mass index, DEXA: Dual-energy X-ray absorption, MRI: Magnetic resonance imaging, 
CT: Computed tomography, HNC: Head and neck cancer, PVM CSA: Paravertebral muscle 
cross sectional area, SM: Skeletal muscle, LSCC: Laryngeal squamous cell carcinoma  
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Summary 
In larynx cancer patients, skeletal  muscle mass  can be estimated using neck muscle index 
from the PVM CSA at the C3 level and this tool may help predict patients at high risk of 
postoperative wound complications before total laryngectomy. 
 
Table Legends 
Table 1: Patient characteristics (n = 60). 
Table 2: Complications for surgical site (n = 22). 
Table 3: Neck muscle index means for no complication and complications groups. 
 
Figure Legends 
Figure 1: Asymmetric enlargement of sternocleidomastoid muscle. Right sternocleidomastoid 
muscle shows asymmetric enlargement (white arrow) due to invasion by metastatic lymph 
node. 
Figure 2: Paravertebral Muscles at C3 Depicted in green. Cross-sectional areas of the muscles 
outlined in green can be seen on axial CT image at C3 vertebrae level.  
Figure 3: Box plot of PVM means between the two groups. Error bars depict 95% confidence 
intervals. Estimated marginal means of PVM between the two groups. Error bars depict 95% 
confidence intervals. 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); XRT, prior 
radiation history; CCI, Charlson comorbidity index; PVM CSA, Paravertebral muscle cross-sectional area 
a Staging based on AJCC, American Joint Committee on Cancer (7th edition). 
b Based on WHO BMI classification.  
 
 
 
 
 
 
 
 
 
Characteristics Datum (n, %) 
Total no. of patients 60 
Age (year) (mean) 59.37 ± 8.40 (range 40–77) 
Flap 6 (10 %) 
Complication 22 (36,6 %) 
Prior Chemo/XRT 9 (15 %) 
T-staginga   T2 14 (23.4 %)  T3 30 (50 %)  T4 16 (26.6 %) 
Preoperative albumin 3,64±0.59  <3,5 g/dL 25 (41.6 %)  ≥3,5 g/dL 35 (58.33 %) 
CCI   <5/ ≥5 37/23 (61.6 % / 38.4 %) 
BMIb, (kg/m2) 23.57±5.13  Underweight (<18.5) 5 (8.4 %)  Normal weight (18.5–24.9) 41 (68.3 %)  Overweight (25.0–29.9) 8 (13.3 %)  Obese (>30.0) 6 (10 %) 
PVM CSA (mm2/m2) (mean) 836.76±187.79 
Smoking status   Current/former/never 28/30/2( 46,6% / 50% / 3,4%)  
Hospital stay time (day) (mean) 19.01±10.22 
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Table 2 
Complications n  
Chyle leak 1 
Seroma, PCF, wound dehiscence and hematoma 1 
Hematoma and seroma 1 
PCF 8 
Seroma 3 
Wound dehiscence 7 
 
PCF: Pharyngocutaneous fistula 
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Table 3 
 Neck muscle 
Index (mm2/m2) 
95% Confidence Interval 
Lower Bound Upper Bound 
No complication 875, 108 815, 247 934, 968 
Complication 770, 531 691, 160 849, 902 
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Figure 1 
 
Right sternocleidomastoid muscle shows asymmetric enlargement (white arrow) due to 
invasion by metastatic lymph node. 
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Figure 2 
 
Cross-sectional areas of the muscles outlined in green can be seen on axial CT image at C3 
vertebrae level.  
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Figure 3 
 
Estimated marginal means of PVM between the two groups. Error bars depict 95% 
confidence intervals. 
 
